发明名称 |
PHARMACEUTICAL COMPOSITION HAVING SYNERGISTIC ACTION OF DIRECT CATALASE INHIBITORS AND MODULATORS OF NO METABOLISM OR OF EXTRACELLULAR SUPEROXIDE ANION PRODUCTION WHICH LEAD TO CATALASE DESTRUCTION |
摘要 |
Composition comprises at least one active ingredient, which brings a singlet oxygen-independent direct catalase inactivation, where the composition further comprises at least one active ingredient, which leads to inactivation of catalase as a result of modulation of the nitrogen oxide or superoxide anion metabolism of the cells and subsequent singlet oxygen formation. ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given. |
申请公布号 |
EP2863907(A1) |
申请公布日期 |
2015.04.29 |
申请号 |
EP20130729758 |
申请日期 |
2013.06.20 |
申请人 |
UNIVERSITÄTSKLINIKUM FREIBURG |
发明人 |
BAUER, GEORG |
分类号 |
A61K31/35;A61K31/055;A61K31/19;A61K31/198;A61K31/337;A61K31/352;A61K31/375;A61K31/454;A61K31/55;A61K39/395;A61P9/00;A61P9/04;A61P9/12;A61P35/00 |
主分类号 |
A61K31/35 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|